In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems - Université de Bretagne Occidentale Access content directly
Journal Articles Thrombosis Research Year : 2018

In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems

No file

Dates and versions

hal-02057877 , version 1 (05-03-2019)

Identifiers

Cite

Philippe Robin, Srishti Kumar, Pierre-Yves Salaun, Pierre-Yves Le Roux, Francis Couturaud, et al.. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems. Thrombosis Research, 2018, 171, pp.97-102. ⟨10.1016/j.thromres.2018.09.050⟩. ⟨hal-02057877⟩
30 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More